Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,166 | -87,703 | -43,754 | -21,518 | N/A |
| Depreciation Amortization | 5,160 | 4,104 | 3,000 | 1,593 | N/A |
| Accounts receivable | -341 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,637 | 3,891 | -223 | 1,434 | N/A |
| Other Working Capital | 2,861 | 4,937 | 323 | 1,627 | N/A |
| Other Operating Activity | 6,853 | -67 | 2,351 | 132 | 0 |
| Operating Cash Flow | $-121,996 | $-74,838 | $-38,303 | $-16,732 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -132,991 | 23,771 | -4,690 | -15,290 | N/A |
| PPE Investments | -5,259 | -5,177 | -5,703 | -3,048 | N/A |
| Investing Cash Flow | $-138,250 | $18,594 | $-10,393 | $-18,338 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,042 | N/A |
| Common Stock Issued | 212,519 | 311 | 489 | 166 | N/A |
| Common Stock Repurchased | N/A | -8 | N/A | -5 | N/A |
| Other Financing Activity | 106,145 | 66,711 | 119,438 | -1,428 | 0 |
| Financing Cash Flow | $318,664 | $67,014 | $119,927 | $-225 | $N/A |
| Beginning Cash Position | 89,232 | 78,462 | 7,231 | 42,526 | N/A |
| End Cash Position | 147,650 | 89,232 | 78,462 | 7,231 | N/A |
| Net Cash Flow | $58,418 | $10,770 | $71,231 | $-35,295 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,996 | -74,838 | -38,303 | -16,732 | N/A |
| Capital Expenditure | -5,259 | -5,177 | -5,703 | -3,048 | N/A |
| Free Cash Flow | -127,255 | -80,015 | -44,006 | -19,780 | 0 |